PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 59 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,084,000 | -73.1% | 3,889,900 | -24.4% | 1.42% | -72.7% |
| Q4 2015 | $15,178,000 | -20.0% | 5,144,916 | -14.3% | 5.23% | +6.0% |
| Q3 2015 | $18,974,000 | +156.4% | 6,004,564 | +380.3% | 4.93% | +142.1% |
| Q2 2015 | $7,401,000 | -50.4% | 1,250,167 | -10.4% | 2.04% | -64.4% |
| Q1 2015 | $14,914,000 | +40.0% | 1,395,167 | +23.0% | 5.72% | -20.7% |
| Q4 2014 | $10,654,000 | – | 1,134,578 | – | 7.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |